• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Gendex finalizes Eureka X-ray Tube acquisition

Article

Gendex continued its acquisition drive with the purchase of EurekaX-ray Tube from Siemens last month. The Des Plaines, IL, manufacturerof dental and medical x-ray systems paid $10.3 million for thebusiness, with $4 million of the price financed

Gendex continued its acquisition drive with the purchase of EurekaX-ray Tube from Siemens last month. The Des Plaines, IL, manufacturerof dental and medical x-ray systems paid $10.3 million for thebusiness, with $4 million of the price financed interest-freeby Siemens, said Edwin J. McDonough, president and COO.

"We think we bought it quite favorably," McDonoughtold SCAN.

Gendex is the leading U.S. supplier of dental x-ray equipment,with a market share over 50%. The firm was started with the acquisitionof GE's dental x-ray business in 1983. It purchased medical x-raymanufacturer Universal/Allied Imaging in 1988. Most recently,Gendex bought the dental x-ray business of Philips late last year(SCAN 1/29/92).

Siemens put Eureka up for sale because the giant German medicalimaging vendor had too many plants. Siemens had purchased an x-raytube manufacturing facility in the former East Germany that thecompany owned prior to World War II, McDonough said.

"They found themselves then with three tube manufacturingfacilities, two in Germany, and Eureka in the U.S.," he said.

Eureka has five different product lines: rotating-anode x-raytubes, stationary-anode tubes, collimators, spot-film devicesand high-voltage cables. Current management will remain in place,and Eureka will continue to be run as an independent business,McDonough said.

Gendex will also maintain the Eureka name, which was establishedwhen the company was founded in 1919. Siemens purchased Eurekain 1988. The firm has about 200 employees and $25 million to $26million in annual revenue, he said.

"It's a good old-line company. We viewed it as a strategicacquisition that will allow us to sell more products through oursame distribution network," McDonough said.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.